Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

13.25 -1.87 (-12.37%)
Official Closing Price Updated: 7:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now
These three worst biotech stocks are not investable even if you're bullish on the sector overall. There are better options. 
Via InvestorPlace
Cathie Wood's Ark Invest Continues Tesla Selling Spree Despite Stock's Rise, AI Potential
 
Via Benzinga
CRM Stock Alert: Salesforce Jumps After Raising Product Prices
Salesforce (CRM) stock is on the rise Tuesday after the cloud services company announced it will be increasing product prices. 
Via InvestorPlace
Microsoft Layoffs 2023: What to Know as MSFT Cuts More Jobs
Microsoft (MSFT) layoffs are on the way as the tech giant prepares to cut even more jobs in 2023 after a major round earlier this year. 
Via InvestorPlace
DNA Stock Alert: Ginkgo Bioworks Moves Forward With Novo Nordisk Partnership
Ginkgo Bioworks (DNA) stock is on the move Tuesday after the company announced a continued partnership with Novo Nordisk. 
Via InvestorPlace
What's Going On With Ginkgo Bioworks (DNA) Stock?
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) shares traded higher Wednesday. 
Via Benzinga
Why Shares Of Ginkgo Bioworks (DNA) Are Up Today
Ginkgo Bioworks Holdings Inc. (NYSE: DNA) shares are up Tuesday in response to recent insider purchases. 
Via Benzinga
Ginkgo Bioworks Holdings: Q1 Earnings Insights
 
Via Benzinga
Earnings Preview: Ginkgo Bioworks Holdings
 
Via Benzinga
Affirm Holdings, Applied Digital And Other Big Stocks Moving Lower On Thursday
U.S. stocks traded lower, with the Dow Jones dropping more than 450 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
2 Growth Stocks Wall Street Thinks Can Soar 90%
Analysts have been trimming their price targets for these stocks -- but are they still too bullish on them? 
Via The Motley Fool
Recent Winners Become Losers For A Day
The large-cap Russell 1,000 fell 0.35% on the day, but more than 2/3 of stocks in the index were actually up on the day, so breadth was quite strong. 
Via Talk Markets
Cathie Wood Trimmed Stake In Microsoft: Here’s What She Bought
Cathie Wood loaded up on shares of PagerDuty and Gingko Bioworks. 
Via Talk Markets
What You Missed On Wall Street On Friday, June 2
Five Top-5 lists, with the news and calls moving stocks. 
Via Talk Markets
Cathie Wood Trimmed This Big Tech Stock Holding But Bulked Up On SaaS Provider PagerDuty And Ginkgo Bioworks
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2023
 
Via Benzinga
Dell, Broadcom, SentinelOne And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
US Stocks Turn Higher; ISM Manufacturing PMI Drops In May
U.S. stocks turned higher midway through trading, with Nasdaq gaining around 100 points on Thursday. The Dow traded up 0.27% to 32,996.06 while the NASDAQ rose 0.76% to 13,034.08. The S&P 500, also... 
Via Benzinga
TheStreetReports: AI Biomedical Companies Disrupting Healthcare: INBS, DNA, IBRX, CDIO
Via AB Newswire
Topics Artificial Intelligence
3 Reasons Why Cathie Wood Is Buying Ginkgo Bioworks Stock Hand Over Fist
The price is right and its future is bright -- but there are risks, too. 
Via The Motley Fool
Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich … or Broke.
These biotech companies are swinging for the fences. They may hit homers, they may strike out. But you'll definitely want to watch them. 
Via InvestorPlace
3 Key Biotech Trends for 2023 And Beyond
New opportunities are becoming apparent, but so are fresh risks in the biotech field. 
Via The Motley Fool
Ginkgo Bioworks Q1 Sales Beat Expectations, But Analyst Downgrades Stock On Guidance Concerns
Ginkgo Bioworks Holdings Inc (NYSE: DNA) reported Q1 sales of $80.70 million, beating the consensus of $71.68 million. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
 
Via Benzinga
Disney, Sonos, Desktop Metal And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Sonos, Inc. (NASDAQ: SONO) shares dipped 25.2% to $15.82 in pre-market... 
Via Benzinga
After-Hours Action: Why Ginkgo Bioworks Stock Is Sliding
Shares of cell programming platform company Ginkgo Bioworks Holdings Inc (NYSE: DNA) are moving lower after hours on the heels of a wider-than-expected quarterly loss.&nbs 
Via Benzinga
DNA Stock Earnings: Ginkgo Bioworks Misses EPS, Beats Revenue Estimates
DNA stock earnings show Ginkgo Bioworks missing analyst estimates for its loss per share but beating revenue estimates. 
Via InvestorPlace
Down 76% From Its High, Can Ginkgo Bioworks Stock Turn Things Around?
Ginkgo is coming off a strong performance in 2022, but this year will no doubt be a more challenging one for the business. 
Via The Motley Fool
7 Best Cathie Wood Stocks for Your May 2023 Buy List
This year promises to be very different for Cathie Wood stocks, as signs of economic improvement become more prominent. 
Via InvestorPlace
Despite Its Falling 92%, Cathie Wood Is Buying More of This Growth Stock
Wood is betting that Ginkgo Bioworks' biofoundry can scale up enough to become profitable. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.